A2M and intrahepatic cholangiocarcinoma: Zhang and collaborators described A2M downregulation in intrahepatic cholangiocarcinoma (ICC) compared to normal bile duct tissue, suggesting this gene’s potential utility as an adverse prognostic factor [25].